share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯维公司 | 144:拟议出售证券
美股SEC公告 ·  12/17 06:37

Moomoo AI 已提取核心信息

Kevin K Buckbee, an officer of AbbVie Inc., is set to sell 1,800 shares of common stock on 12/16/2024. The transaction, resulting from a stock option exercise, has an estimated aggregate market value of $310,045.14.The shares were acquired on the same date (12/16/2024) through a stock option exercise from the issuer as part of compensation. This planned sale represents the entirety of the shares obtained from this particular option exercise.Notably, the company's records indicate no other securities sold by Buckbee in the past three months. The official notice for this transaction was filed on 12/16/2024, aligning with both the acquisition and planned sale date of the shares.
Kevin K Buckbee, an officer of AbbVie Inc., is set to sell 1,800 shares of common stock on 12/16/2024. The transaction, resulting from a stock option exercise, has an estimated aggregate market value of $310,045.14.The shares were acquired on the same date (12/16/2024) through a stock option exercise from the issuer as part of compensation. This planned sale represents the entirety of the shares obtained from this particular option exercise.Notably, the company's records indicate no other securities sold by Buckbee in the past three months. The official notice for this transaction was filed on 12/16/2024, aligning with both the acquisition and planned sale date of the shares.
Kevin k Buckbee,AbbVie Inc.的一名高管,计划于2024年12月16日出售1,800股普通股。此次交易是由于行使股票期权,预计总市场价值为310,045.14美元。这些股票是在同一天(2024年12月16日)通过行使股票期权从发行方获得,作为薪酬的一部分。这次计划出售代表了通过这个特定期权行使获得的所有股票。值得注意的是,公司记录显示Buckbee在过去三个月内没有出售其他证券。此交易的正式通知已于2024年12月16日提交,与股票的获得和计划出售日期一致。
Kevin k Buckbee,AbbVie Inc.的一名高管,计划于2024年12月16日出售1,800股普通股。此次交易是由于行使股票期权,预计总市场价值为310,045.14美元。这些股票是在同一天(2024年12月16日)通过行使股票期权从发行方获得,作为薪酬的一部分。这次计划出售代表了通过这个特定期权行使获得的所有股票。值得注意的是,公司记录显示Buckbee在过去三个月内没有出售其他证券。此交易的正式通知已于2024年12月16日提交,与股票的获得和计划出售日期一致。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息